Company Description
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions.
Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
| Country | United States |
| Founded | 1967 |
| IPO Date | Dec 17, 1996 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 56,000 |
| CEO | James Davis |
Contact Details
Address: 500 Plaza Drive Secaucus, New Jersey 07094 United States | |
| Phone | 973 520 2700 |
| Website | questdiagnostics.com |
Stock Details
| Ticker Symbol | DGX |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001022079 |
| CUSIP Number | 74834L100 |
| ISIN Number | US74834L1008 |
| Employer ID | 16-1387862 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| James E. Davis | Chairman, Chief Executive Officer and President |
| Sam A. Samad | Executive Vice President and Chief Financial Officer |
| Michael E. Prevoznik J.D. | Senior Vice President and General Counsel |
| Catherine T. Doherty | Executive Vice President of Regional Businesses |
| Karthik Kuppusamy Ph.D. | Senior Vice President of Clinical Solutions |
| Michael J. Deppe | Senior Vice President, Corporate Controller and Chief Accounting Officer |
| Murali Balakumar | Senior Vice President and Chief Information and Digital Officer |
| Shawn C. Bevec | Vice President of Investor Relations |
| Kristin Lee Wallace Esq. | Senior Vice President and Chief Compliance Officer |
| Garry Clark | Senior Vice President and Chief Marketing and Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 20, 2025 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 20, 2025 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| May 22, 2025 | 8-K | Current Report |
| May 14, 2025 | SCHEDULE 13G | Filing |
| May 13, 2025 | 144 | Filing |
| May 12, 2025 | 144 | Filing |
| Apr 23, 2025 | 10-Q | Quarterly Report |
| Apr 22, 2025 | 8-K | Current Report |
| Apr 17, 2025 | SCHEDULE 13G/A | Filing |
| Apr 11, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |